INM
InMed Pharmaceuticals Inc
NASDAQ: INM · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.70
+0.00% today
Updated 2026-04-29
Market cap
$2.43M
P/E ratio
—
P/S ratio
0.54x
EPS (TTM)
$-2.88
Dividend yield
—
52W range
$1 – $6
Volume
0.1M
InMed Pharmaceuticals Inc (INM) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.76M | $825792.00 | $623372.00 | $168422.00 | $79463.00 | $39658.00 | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.09M | $4.14M | $4.60M | $4.94M |
| Revenue growth (YoY) | — | -70.1% | -24.5% | -73.0% | -52.8% | -50.1% | -100.0% | — | — | — | — | — | — | — | — | — | — | +279.6% | +11.2% | +7.5% |
| Cost of revenue | $1.42M | $319779.00 | $405578.00 | $108889.00 | $8756.00 | $27361.00 | — | — | — | — | — | — | $92777.00 | $93940.00 | $183090.00 | $197031.00 | $545889.00 | $2.73M | $3.50M | $3.24M |
| Gross profit | $1.34M | $506013.00 | $217794.00 | $59533.00 | $70707.00 | $12297.00 | — | — | — | — | — | — | $-92777.00 | $-93940.00 | $-183090.00 | $-197031.00 | $543546.00 | $1.40M | $1.10M | $1.71M |
| Gross margin | 48.7% | 61.3% | 34.9% | 35.3% | 89.0% | 31.0% | — | — | — | — | — | — | — | — | — | — | 49.9% | 33.9% | 23.9% | 34.5% |
| R&D | — | $204702.00 | $236233.00 | $116937.00 | $118418.00 | — | $17031.00 | — | $57872.00 | $759851.00 | $292840.00 | $573723.00 | $1.52M | $4.30M | $5.81M | $6.62M | $7.28M | $3.73M | $3.22M | $2.85M |
| SG&A | $2.52M | $1.40M | $1.19M | $372511.00 | $237275.00 | $287000.00 | $154162.00 | $46747.00 | $1.09M | $2.62M | $1.48M | $2.79M | $4.99M | $6.00M | $3.50M | $5.55M | $6.87M | $5.85M | $5.80M | $6.56M |
| Operating income | $-1.18M | $-1.14M | $-1.27M | $-776998.00 | $-411402.00 | $-387556.00 | $-168718.00 | $-49186.00 | $-1.15M | $-3.45M | $-1.84M | $-3.44M | $-6.78M | $-10.36M | $-9.15M | $-12.17M | $-13.79M | $-8.38M | $-8.13M | $-7.92M |
| Operating margin | -42.6% | -138.4% | -203.7% | -461.3% | -517.7% | -977.2% | — | — | — | — | — | — | — | — | — | — | -1266.0% | -202.6% | -176.9% | -160.2% |
| EBITDA | $-920788.00 | $-973420.00 | $-1.19M | $-608237.00 | $-341899.00 | $-178248.00 | $-168585.00 | $-46747.00 | $-1.15M | $-3.38M | $-1.77M | $-3.36M | $-6.69M | $-10.26M | $-8.76M | $-12.17M | $-13.28M | $-7.78M | $-7.06M | $-7.26M |
| EBITDA margin | -33.4% | -117.9% | -190.4% | -361.1% | -430.3% | -449.5% | — | — | — | — | — | — | — | — | — | — | -1219.0% | -188.2% | -153.6% | -146.8% |
| EBIT | $-1.17M | $-1.14M | $-1.27M | $-776997.00 | $-411401.00 | $-313764.00 | $-168718.00 | $-49186.00 | $-1.15M | $-3.45M | $-1.84M | $-3.44M | $-6.77M | $-10.36M | $-8.94M | $-12.32M | $-13.79M | $-8.38M | $-7.67M | $-7.79M |
| Interest expense | $20145.00 | $17470.00 | $230102.00 | $5900.00 | $27633.00 | $11702.00 | $16.00 | $10.00 | $1692.00 | $3525.00 | $47.00 | $495.00 | $67166.00 | $330441.00 | $18616.00 | $360350.00 | $96090.00 | — | $0.00 | $373105.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-1.27M | $-1.87M | $-922260.00 | $-1.06M | $-334787.00 | $-325466.00 | $-189915.00 | $-46737.00 | $-1.15M | $-3.46M | $-1.84M | $-3.44M | $-6.71M | $-10.01M | $-8.94M | $-12.65M | $-18.60M | $-7.95M | $-7.68M | $-8.16M |
| Net income growth (YoY) | — | -47.3% | +50.8% | -14.9% | +68.4% | +2.8% | +41.6% | +75.4% | -2365.2% | -200.1% | +46.9% | -87.2% | -95.0% | -49.2% | +10.7% | -41.5% | -47.0% | +57.3% | +3.4% | -6.3% |
| Profit margin | -46.1% | -227.0% | -147.9% | -629.3% | -421.3% | -820.7% | — | — | — | — | — | — | — | — | — | — | -1707.3% | -192.2% | -166.9% | -165.1% |